Loading...

AMRX AMNEAL PHARMACEUTICALS INC Earnings Reports 8-K Filing

MNL

MRX

AMNEAL PHARMACEUTICALS INC

(AMRX)

2024 8-K

Q3 Earnings Report

Financial Statements

Debt Restructuring

Debt Restructuring

Debt-Equity Swaps

Appointing directors

Financial Statements

Earnings Announcement

2024 Financial Guidance

Earnings Update

Q3 Earnings Report

Strategic Collaboration

Earnings Reports

Annual Meeting of Stockholders

Reaffirmation of Guidance

Product Launch/Discontinuation

Amendment and New Credit Ag...

Reorganization Plan

Financial Results Announcement

Quantitative Data

Settlement Agreement

Annual Meeting Results

Financial Results Announcement

Reaffirmation of Financial ...

External Links:

Amneal Pharmaceuticals reaffirms guidance for the year ended December 31, 2023, with net revenue estimated at $2.37 billion - $2.42 billion and adjusted EBITDA at $540 million - $550 million.

AI Assistant

AMNEAL PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.